Global Injectable Drugs Market Research Report 2024

Report ID: 1988404 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
1 Injectable Drugs Market Overview
    1.1 Product Overview and Scope of Injectable Drugs
    1.2 Injectable Drugs Segment by Packaging Type
        1.2.1 Global Injectable Drugs Sales Growth Rate Comparison by Packaging Type (2022-2028)
        1.2.2 Ampoules
        1.2.3 Vials
        1.2.4 Cartridges
        1.2.5 Bottles
    1.3 Injectable Drugs Segment by Application
        1.3.1 Global Injectable Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Home Care
        1.3.5 Others
    1.4 Global Injectable Drugs Market Size Estimates and Forecasts
        1.4.1 Global Injectable Drugs Revenue 2017-2028
        1.4.2 Global Injectable Drugs Sales 2017-2028
        1.4.3 Injectable Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Injectable Drugs Market Competition by Manufacturers
    2.1 Global Injectable Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Injectable Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Injectable Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Injectable Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Injectable Drugs Market Competitive Situation and Trends
        2.5.1 Injectable Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Injectable Drugs Players Market Share by Revenue
        2.5.3 Global Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Drugs Retrospective Market Scenario by Region
    3.1 Global Injectable Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Injectable Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Injectable Drugs Market Facts & Figures by Country
        3.3.1 North America Injectable Drugs Sales by Country
        3.3.2 North America Injectable Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Injectable Drugs Market Facts & Figures by Country
        3.4.1 Europe Injectable Drugs Sales by Country
        3.4.2 Europe Injectable Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Injectable Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Injectable Drugs Sales by Region
        3.5.2 Asia Pacific Injectable Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Injectable Drugs Market Facts & Figures by Country
        3.6.1 Latin America Injectable Drugs Sales by Country
        3.6.2 Latin America Injectable Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Injectable Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Injectable Drugs Sales by Country
        3.7.2 Middle East and Africa Injectable Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Injectable Drugs Historic Market Analysis by Packaging Type
    4.1 Global Injectable Drugs Sales Market Share by Packaging Type (2017-2022)
    4.2 Global Injectable Drugs Revenue Market Share by Packaging Type (2017-2022)
    4.3 Global Injectable Drugs Price by Packaging Type (2017-2022)
5 Global Injectable Drugs Historic Market Analysis by Application
    5.1 Global Injectable Drugs Sales Market Share by Application (2017-2022)
    5.2 Global Injectable Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global Injectable Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 AbbVie
        6.1.1 AbbVie Corporation Information
        6.1.2 AbbVie Description and Business Overview
        6.1.3 AbbVie Injectable Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 AbbVie Injectable Drugs Product Portfolio
        6.1.5 AbbVie Recent Developments/Updates
    6.2 F. Hoffmann-La Roche
        6.2.1 F. Hoffmann-La Roche Corporation Information
        6.2.2 F. Hoffmann-La Roche Description and Business Overview
        6.2.3 F. Hoffmann-La Roche Injectable Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 F. Hoffmann-La Roche Injectable Drugs Product Portfolio
        6.2.5 F. Hoffmann-La Roche Recent Developments/Updates
    6.3 GlaxoSmithKline
        6.3.1 GlaxoSmithKline Corporation Information
        6.3.2 GlaxoSmithKline Description and Business Overview
        6.3.3 GlaxoSmithKline Injectable Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 GlaxoSmithKline Injectable Drugs Product Portfolio
        6.3.5 GlaxoSmithKline Recent Developments/Updates
    6.4 Sanofi
        6.4.1 Sanofi Corporation Information
        6.4.2 Sanofi Description and Business Overview
        6.4.3 Sanofi Injectable Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Sanofi Injectable Drugs Product Portfolio
        6.4.5 Sanofi Recent Developments/Updates
7 Injectable Drugs Manufacturing Cost Analysis
    7.1 Injectable Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Injectable Drugs
    7.4 Injectable Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Injectable Drugs Distributors List
    8.3 Injectable Drugs Customers
9 Injectable Drugs Market Dynamics
    9.1 Injectable Drugs Industry Trends
    9.2 Injectable Drugs Market Drivers
    9.3 Injectable Drugs Market Challenges
    9.4 Injectable Drugs Market Restraints
10 Global Market Forecast
    10.1 Injectable Drugs Market Estimates and Projections by Packaging Type
        10.1.1 Global Forecasted Sales of Injectable Drugs by Packaging Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Injectable Drugs by Packaging Type (2023-2028)
    10.2 Injectable Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Injectable Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Injectable Drugs by Application (2023-2028)
    10.3 Injectable Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Injectable Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Injectable Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Injectable Drugs Sales Growth Rate Comparison by Packaging Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Injectable Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Injectable Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Injectable Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Injectable Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Injectable Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Injectable Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Injectable Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Injectable Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Injectable Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Injectable Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Injectable Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Injectable Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Injectable Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Injectable Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Injectable Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Injectable Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Injectable Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Injectable Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Injectable Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Injectable Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Injectable Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Injectable Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Injectable Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Injectable Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Injectable Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Injectable Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Injectable Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Injectable Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Injectable Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Injectable Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Injectable Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Injectable Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Injectable Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Injectable Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Injectable Drugs Sales by Packaging Type (2017-2022) & (K Units)
    Table 40. Global Injectable Drugs Sales Market Share by Packaging Type (2017-2022)
    Table 41. Global Injectable Drugs Revenue by Packaging Type (2017-2022) & (US$ Million)
    Table 42. Global Injectable Drugs Revenue Share by Packaging Type (2017-2022)
    Table 43. Global Injectable Drugs Price by Packaging Type (2017-2022) & (USD/Unit)
    Table 44. Global Injectable Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Injectable Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Injectable Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Injectable Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Injectable Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. AbbVie Corporation Information
    Table 50. AbbVie Description and Business Overview
    Table 51. AbbVie Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. AbbVie Injectable Drugs Product
    Table 53. AbbVie Recent Developments/Updates
    Table 54. F. Hoffmann-La Roche Corporation Information
    Table 55. F. Hoffmann-La Roche Description and Business Overview
    Table 56. F. Hoffmann-La Roche Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. F. Hoffmann-La Roche Injectable Drugs Product
    Table 58. F. Hoffmann-La Roche Recent Developments/Updates
    Table 59. GlaxoSmithKline Corporation Information
    Table 60. GlaxoSmithKline Description and Business Overview
    Table 61. GlaxoSmithKline Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. GlaxoSmithKline Injectable Drugs Product
    Table 63. GlaxoSmithKline Recent Developments/Updates
    Table 64. Sanofi Corporation Information
    Table 65. Sanofi Description and Business Overview
    Table 66. Sanofi Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Sanofi Injectable Drugs Product
    Table 68. Sanofi Recent Developments/Updates
    Table 69. Production Base and Market Concentration Rate of Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Injectable Drugs Distributors List
    Table 72. Injectable Drugs Customers List
    Table 73. Injectable Drugs Market Trends
    Table 74. Injectable Drugs Market Drivers
    Table 75. Injectable Drugs Market Challenges
    Table 76. Injectable Drugs Market Restraints
    Table 77. Global Injectable Drugs Sales Forecast by Packaging Type (2023-2028) & (K Units)
    Table 78. Global Injectable Drugs Sales Market Share Forecast by Packaging Type (2023-2028)
    Table 79. Global Injectable Drugs Revenue Forecast by Packaging Type (2023-2028) & (US$ Million)
    Table 80. Global Injectable Drugs Revenue Market Share Forecast by Packaging Type (2023-2028)
    Table 81. Global Injectable Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 82. Global Injectable Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 83. Global Injectable Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 84. Global Injectable Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 85. Global Injectable Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 86. Global Injectable Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 87. Global Injectable Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 88. Global Injectable Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Injectable Drugs
    Figure 2. Global Injectable Drugs Market Share by Packaging Type in 2021 & 2028
    Figure 3. Ampoules Product Picture
    Figure 4. Vials Product Picture
    Figure 5. Cartridges Product Picture
    Figure 6. Bottles Product Picture
    Figure 7. Global Injectable Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospital
    Figure 9. Clinic
    Figure 10. Home Care
    Figure 11. Others
    Figure 12. Global Injectable Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Injectable Drugs Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Injectable Drugs Sales (2017-2028) & (K Units)
    Figure 15. Injectable Drugs Sales Share by Manufacturers in 2021
    Figure 16. Global Injectable Drugs Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Injectable Drugs Players: Market Share by Revenue in 2021
    Figure 18. Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Injectable Drugs Sales Market Share by Region (2017-2022)
    Figure 20. Global Injectable Drugs Sales Market Share by Region in 2021
    Figure 21. Global Injectable Drugs Revenue Market Share by Region (2017-2022)
    Figure 22. Global Injectable Drugs Revenue Market Share by Region in 2021
    Figure 23. U.S. Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Taiwan Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Philippines Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Vietnam Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Turkey Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Saudi Arabia Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. U.A.E Injectable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Sales Market Share of Injectable Drugs by Packaging Type (2017-2022)
    Figure 48. Manufacturing Cost Structure of Injectable Drugs
    Figure 49. Manufacturing Process Analysis of Injectable Drugs
    Figure 50. Injectable Drugs Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Sanofi
Frequently Asked Questions
Injectable Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Injectable Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Injectable Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Inkjet Heads

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Inorganic Pigment

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More